XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income (loss) $ 10,627 $ (7,627)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 48,453 54,623
Non-cash operating lease costs 2,770 2,933
Share-based compensation 8,872 8,402
Provision for credit losses on accounts receivable 50 441
Deferred income taxes, net (2,709) (7,442)
Loss on sale of businesses 3,780 0
Loss from equity method investments 645 9,182
Unrealized loss on short-term investments held at the reporting date, net 10,705 20,345
Gain on investments, net 0 (357)
Other 1,278 2,776
Decrease (increase) in:    
Accounts receivable 55,365 27,626
Prepaid expenses and other current assets (9,423) (7,658)
Other assets (2,078) (2,048)
Increase (decrease) in:    
Accounts payable (62,270) 6,922
Deferred revenue 15,169 12,085
Accrued liabilities and other current liabilities (5,676) (4,896)
Net cash provided by operating activities 75,558 115,307
Cash flows from investing activities:    
Purchases of property and equipment (28,129) (30,017)
Acquisition of businesses, net of cash received (44,524) (8,001)
Proceeds from sale of equity investments 0 3,174
Proceeds from sale of businesses, net of cash divested 1,238 0
Other (66) (3,947)
Net cash used in investing activities (71,481) (38,791)
Cash flows from financing activities:    
Repurchase of common stock (3,923) (2,875)
Deferred payments for acquisitions (2,418) (6,679)
Other 30 71
Net cash used in financing activities (6,311) (9,483)
Effect of exchange rate changes on cash and cash equivalents (599) 1,676
Net change in cash and cash equivalents (2,833) 68,709
Cash and cash equivalents at beginning of period 737,612 652,793
Cash and cash equivalents at end of period $ 734,779 $ 721,502